Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol timing and immune response after hepatitis B vaccination in adults
NL-OMON38027Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Aug 2011
- Modality
- Small Molecules, Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of acetaminophen and Hepatitis B vaccine in hepatitis B (HBV) (3 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Antibody concentration before and 1 month after third vaccination (Phase 1) and Antibody concentration before and 1 month after third vaccination (Phase 2). Started Aug 2011; status: active, not recruiting.
02
Drugs
acetaminophenHepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NL-OMON38027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38027.